MSB 2.89% $1.25 mesoblast limited

The FDA’s slow & methodical regulatory maze has slowly choked...

  1. 6,362 Posts.
    lightbulb Created with Sketch. 379
    The FDA’s slow & methodical regulatory maze has slowly choked the company’s resources to the edge several times…..we need that first approval as a lifeblood…. only then will those often ‘advanced’ funding agreements & partnerships materialise.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.